USOR 25010 - STAR Ph4 study of Ocular in patients with Tivdak in cervical cancer (GOG-3116)

A Prospective Low-Interventional Phase 4 Single Arm Study of Ocular Assessments in Patients Treated with Tivdak in Recurrent or Metastatic Cervical Cancer

Disease Types: STAR: Selected Trials Available for Accelerated Four Week Rollout

Available at: Arlington Heights, Chicago, Niles